NCT03473743 2025-12-23A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial CancerJanssen Research & Development, LLCPhase 1/2 Active not recruiting125 enrolled 19 charts
NCT05052372 2022-12-22Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving ErdafitinibxCuresTerminated2 enrolled